The main topic will most likely be AI, according to MarketWatch / Photo: X/SpaceX
News·
"A Roller-Coaster Ride for Stocks": What Wall Street Is Saying Ahead of SpaceX's Earnings Report
Ark notes that robotaxis can remain profitable even with lower fares / Photo: Dolores M. Harvey / Shutterstock.com
News·
Why Cathie Wood's team expects Tesla's stock to rise by more than 1,000%
For now, the stock market is weathering the rise in bond yields, but the outlook beyond that is becoming increasingly uncertain, according to J.P. Morgan / Photo: Shutterstock.com
News·
"A Vicious Cycle": What Risks Does Rising Bond Yields Pose to the Stock Market?
Yields on French government bonds are rising again / Photo: pmvfoto / Shutterstock
News·
"The Weak Link": The risk premium on French government bonds has approached a 15-year high
Small Caps·
Veradermics jumps on successful hair-loss pill trial. Is the stock a buy?
Review·
Digital Twins: Why Kazakhstan Is Implementing Artificial Intelligence in Industry
News·
General Motors announced a $20 billion buyback. Why did its stock price fall?
News·
Political risks have made French stocks a prime target for short sellers in Europe
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Disc stock jumped 39% after a successful trial for its drug bitopertin, its best day since late 2022 / Photo: www.discmedicine.com
Small Caps·
Disc Medicine has best day in 4 years as its blood-disorder drug succeeds in trial
Small Caps·
+1
·
From PDFs to drone defense: How Finland’s newest billionaire built his business
Small Caps·
Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug
Small Caps·
Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal
Small Caps·
Needham makes case for obesity drugs as long-term catalyst for Victoria’s Secret
Go to section

Investment and Finance News